![]() |
市场调查报告书
商品编码
1642742
按产品类型(胰岛素帮浦、胰岛素帮浦耗材和配件)、配销通路(医院药房、零售药房、线上销售、糖尿病诊所/中心等)和地区分類的胰岛素帮浦市场报告2025-2033Insulin Pumps Market Report by Product Type (Insulin Pumps, Insulin Pump Supplies and Accessories), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/ Centers, and Others), and Region 2025-2033 |
2024年,全球IMARC Group帮浦市场规模达到56亿美元。市场的推动因素包括糖尿病患者数量的增加、个人收入的增加、人们对产品益处的认识不断增强以及医疗保健支出的增加。
胰岛素帮浦是小型电脑化医疗设备,可以夹在腰带、口袋或隐藏在衣服下。该帮浦用于根据消费者的基础和推注率定期在体内输送受控剂量的胰岛素,以控制血糖水平的上升。它透过一根针和一根柔性导管进行操作,用于将胰岛素直接插入脂肪组织,然后用胶带粘住并固定到位。胰岛素帮浦透过为 1 型和 2 型糖尿病患者提供食物选择和饮食计划的灵活性并减少注射次数来帮助他们。
全球糖尿病盛行率不断上升以及健康意识不断提高是市场成长的关键因素。经济现代化显着增加了多种生活方式疾病的发生,特别是糖尿病。饮食偏好的改变和对含有人工成分和防腐剂的即食包装食品的依赖进一步加剧了这种情况。由于糖尿病会引发其他慢性疾病,如肾衰竭、中风、瘫痪和失明,製造商越来越重视创造适应性强且价格实惠的设备。此外,由于高精度血糖感测器和血液监测设备的发展,对高效能胰岛素帮浦的需求也有所增加。此外,人均医疗保健服务支出的增加以及改善胰岛素帮浦功能的研究和开发的增加等因素也促进了市场的成长。
The global insulin pumps market size reached USD 5.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is driven by the increasing number of people with diabetes, the rising incomes of individuals, the growing awareness about the benefits of the product, and the growing spending on healthcare.
Insulin pumps are small computerized medical devices that can be clipped on to a belt, pocket or hidden under the clothes. The pump is used to deliver controlled doses of insulin inside the body at regular intervals, depending upon the consumer's basal and bolus rate, to control the rise in blood glucose levels. It operates through a needle and a flexible catheter that is used to insert insulin directly into the fatty tissue, which is then taped and secured in place. Insulin pumps assist individuals suffering from type 1 and type 2 diabetes by providing them flexibility in food options and eating schedules and reduces the number of injection administrations.
The increasing prevalence of diabetes across the globe and rising health awareness are the key factors for market growth. Modernization of economies has significantly enhanced the occurrence of several lifestyle diseases, especially diabetes. This is further augmented by changing dietary preferences and dependency on ready-to-eat packaged food containing artificial ingredients and preservatives. Since diabetes can trigger the occurrence of other chronic conditions such as kidney failure, stroke, paralysis and blindness, manufacturers are increasingly emphasizing on creating adaptive and affordable devices. Additionally, due to the development of highly accurate glucose sensors and blood monitoring devices, the demand for efficient insulin pumps has also increased. Furthermore, factors such as rising per capita expenditure on healthcare services and increasing research and development for improving the functioning of insulin pumps have also contributed to market growth.
Insulin Pumps
Tethered Pumps
Disposable/Patch Insulin Pumps
Insulin Pump Supplies and Accessories
Infusion Set Insertion Devices
Insulin Reservoirs/Cartridges
Hospital Pharmacy
Retail Pharmacy
Online Sales
Diabetes Clinics/ Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being EOFlow Co. Ltd., Insulet Corp., Medtronic plc, MicroPort Scientific Corporation., Microtech Medical, Roche Diabetes Care Limited, Sooil Development Co. Ltd., Tandem Diabetes Care Inc., Terumo Europe NV (Terumo Corporation), Ypsomed, etc.